Pharmaceutical Business review

BD Diagnostics, Lab21 in Aspergillus diagnostic assay development agreement

Upon the development, Aspergillus fungus will be detected using BD MAX Molecular Testing System.

Lab21 CEO Graham Mullis said the potential to detect Aspergillus in blood using real-time polymerase chain reaction aids clinicians to accurately diagnose and screen the early and definitive detection of aspergillosis.

BD Diagnostics Diagnostic Systems president Tom Polen said BD plans to bring new assays to the BD MAX System in a broad range of disease categories.